Navamedic ASA

Navamedic ASA, a medtech and pharmaceutical company, in-licenses, buys, and markets pharmaceuticals and other health care products in Northern European region. The company operates through two segments, Pharma and Healthcare Products, and Medtech. Its product portfolio includes original and generic pharmaceuticals, as well as food supplements, medical devices, and other health care products. The company also distributes medical nutrition products for various metabolic disorders, including phenylketonuria, tyrosinemia, maple sirup urine disease, homocystinuria, methylmalonic acidemia, propionic acidemia, and glutaric aciduria type 1, as well as carbohydrate metabolism, fat metabolism, and renal diseases. In addition, it sells consumer care products consisting non-prescription drugs, pharmaceuticals, and health care products primarily through pharmacies and drugstores. Further, the company offers Sippi, a digital urine meter, which measures biofilm build-up through non-contact capacitive sensor; and Re5-NTS, a treatment concept that uses electrical pulses as treatment in patients with refractory depression. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was founded in 2002 and is headquartered in Lysaker, Norway.